# QTc Study of Rosi XR in Healthy Volunteers

> **NCT00884533** · PHASE1 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Rosi XR
- **OTHER:** Placebo
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT00884533
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-06
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The whole project was terminated
- **Last updated:** 2015-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00884533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00884533, "QTc Study of Rosi XR in Healthy Volunteers". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00884533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*